200
Participants
Start Date
November 30, 2004
Primary Completion Date
September 30, 2006
Study Completion Date
September 30, 2006
LPV/RTV + 2NRTIs
Tablets, Oral, Variable, Twice daily, 48 weeks.
LPV/RTV + 2NRTIs
Tablets, Oral, Variable, Twice daily, 48 weeks.
Local Institution, Phoenix
Local Institution, Altamonte Springs
Local Institution, Fort Lauderdale
Local Institution, Vero Beach
Local Institution, Honolulu
Local Instution, Wichita
Local Instution, Lexington
Local Institution, Louisville
Local Institution, East Orange
Local Institution, Albany
Local Institution, Huntersville
Local Institution, Portland
Local Institution, Dallas
Local Institution, Buenos Aires
Local Institution, Capital Federal
Local Institution, La Plata
Local Institution, Mar del Plata
Local Institution, Córdoba
Local Institution, Rosario
Local Institution, Buenos Aires
Local Institution, Curitiba
Local Institution, Recife
Local Institution, Rio de Janeiro
Local Institution, Campinas
Local Institution, São Paulo
Local Institution, Guatemala City
Local Institution, Durango
Local Institution, Guadalajara
Local Institution, Lima
Local Institution, Port Elizabeth
Local Institution, Bloemfontein
Local Institution, Bedford Gardens
Local Institution, Johannesburg
Local Institution, Meadowdale
Local Institution, Westdene
Local Institution, Mowbray
Local Institution, Rugby
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY